Related Experiment Video
Updated: May 20, 2026
12:32
High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Metal ions affect insulin-degrading enzyme activity
Giuseppe Grasso1, Fabrizio Salomone, Grazia R Tundo
1Dipartimento di Scienze Chimiche, Università di Catania, Viale Andrea Doria 6, 95125 Catania, Italy. grassog@unict.it
Journal of Inorganic Biochemistry
|July 24, 2012
Summary
Insulin-degrading enzyme (IDE) activity is crucial for controlling insulin action. Copper(I) ions irreversibly inhibit IDE, while copper(II) ions allow substrate processing, revealing metal ion-specific effects on insulin degradation.
Area of Science:
- Biochemistry
- Enzymology
- Metalloprotein
Background:
- Insulin degradation is vital for regulating insulin's biological activity.
- Insulin-degrading enzyme (IDE) is the primary enzyme responsible for insulin breakdown.
- Dysregulation of metal ion homeostasis is linked to metabolic disorders like diabetes mellitus.
Purpose of the Study:
- To investigate the impact of various metal ions on the proteolytic activity of IDE towards insulin.
- To explore the differential effects of copper(I) and copper(II) on IDE's enzymatic function.
- To understand the biomolecular mechanisms underlying IDE-substrate interactions modulated by metal ions.
Main Methods:
- Enzymatic assays to measure IDE proteolytic activity.
- Use of insulin and a designed insulin B chain peptide (B20-30) as substrates.
- Investigation of metal ion (copper, aluminum, zinc) effects on IDE function.
Main Results:
- IDE activity is irreversibly inhibited by copper(I) ions.
- IDE retains substrate processing capability when bound to copper(II) ions.
- Metal ion modulation of IDE activity is substrate-dependent, with varying effects on insulin and peptide substrates.
Conclusions:
- Copper ions differentially regulate IDE activity, with distinct effects of copper(I) and copper(II) oxidation states.
- These findings provide insights into the metallo-regulation of insulin degradation and its potential implications in diabetes.
- Targeting IDE activity through metal ion interactions offers a potential therapeutic avenue for metabolic disorders.
More Related Videos
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...